Actin review

Almost every provider reviewed here either charges the same for a small dose as for a large one, or declines to price the small dose at all. This one does something different and worse: it prices the microdose higher than the standard product. A named GLP-1 Microdose is listed at a monthly figure noticeably above the starting price of the standard GLP-1 line, and both sit in the same product grid where anyone can compare them in a glance. Nothing is concealed about it, which makes it a pricing decision rather than a trick — but it inverts the only economic case there is for taking less drug. A reader choosing the microdose here is paying a premium for a smaller quantity of the same molecule, and should go in clear that this is the trade being made rather than discovering it later. There are real merits around it. The microdose is offered in both the women’s and the men’s ranges rather than to one group, the standard line names which molecules it contains instead of selling an unspecified GLP-1, and the site says plainly that there are no video calls, which suits people who want the prescription without the appointment. But on this site’s central question, the answer here is that holding low costs more.

Vs median

$53/mo below the $169 median across the 242 of 373 programs we track that publish a plain monthly rate

Market

$59–$1300/mo is the full published spread in our ranking

Structure

Prices the low dose on its own

Consult

Included in the price

Dietitian

Not included

Labs

Not required

Pricing

Varies by dose, plan or tier

Price last updated

August 2026

Actin dispenses through a Not named facility. No bloodwork is required before you start. A clinician review is included in the price.

Almost every provider reviewed here either charges the same for a small dose as a large one, or does not price the small dose at all. This one does something different and worse: it prices the microdose higher than the standard product. A named GLP-1 Microdose is listed at a monthly figure noticeably above the starting price of the standard GLP-1 line, and both sit in the same grid where anyone can compare them. Nothing is concealed about it — which makes it a pricing decision rather than a trick — but it inverts the only economic case for taking less. A reader choosing the microdose here is paying a premium for a smaller quantity of the same molecule, and should be clear that is the trade they are making. There are real merits around it. The microdose appears in both the women's and men's ranges rather than being offered to one, the standard line names which molecules it contains, and the site states plainly that there are no video calls, which suits people who want the prescription without the appointment. But on this site's central question, the answer here is that holding low costs more.

The microdose is priced above the standard GLP-1, so taking less costs more.

• The standard line is shown against a struck-through higher figure with no end date.
• No dose in milligrams is published behind any figure.

Actin is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

• Low dose vs full dose
• What microdosing GLP-1 costs
• What a flat price costs at a low dose
• The true annual cost of a plan